Oppenheimer Asset Management Inc. Amneal Pharmaceuticals, Inc. Transaction History

Oppenheimer Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$2.29 - $7.1 $87 - $269	-38 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$6.44 - $14.29 $117,407 - $260,520	-18,231 Reduced 99.79%	38 $0
Q1 2019 Apr 24, 2019	BUY	$11.87 - $14.84 $21,698 - $27,127	1,828 Added 11.12%	18,269 $259,000
Q4 2018 Jan 30, 2019	SELL	$13.09 - $21.49 $64,572 - $106,010	-4,933 Reduced 23.08%	16,441 $222,000
Q3 2018 Oct 26, 2018	BUY	$16.4 - $24.27 $15,104 - $22,352	921 Added 4.5%	21,374 $474,000
Q2 2018 Aug 10, 2018	BUY	$13.95 - $20.2 $285,319 - $413,150	20,453 New	20,453 $336,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.